Influence of β-adrenoceptor antagonists on hemorrhage-induced cellular immune suppression

Shock

Volumn 18, Issue 4, 2002, Pages 331-335

  Oberbeck, Reiner ^a   Van Griensven, Martijn ^b   Nickel, Eike ^b   Tschernig, Thomas ^b   Wittwer, Tobias ^b   Pape, Hans Christoph ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Apoptosis; Endocrine system; Hemorrhagic shock; Immune system; Lymphocyte; Metoprolol; Propranolol; Trauma

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; METOPROLOL; PROPRANOLOL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; APOPTOSIS; ARTICLE; BLOOD; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; HEMORRHAGIC SHOCK; IMMUNOLOGY; LYMPHOCYTE; MALE; METABOLISM; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; PATHOLOGY; SPLEEN;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; APOPTOSIS; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; IMMUNITY, CELLULAR; INTERLEUKIN-10; KILLER CELLS, NATURAL; LYMPHOCYTES; MALE; METOPROLOL; MICE; MICE, INBRED STRAINS; PROPRANOLOL; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; SHOCK, HEMORRHAGIC; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036782062     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200210000-00007     Document Type: Article

References (30)

1. Faist E, Meakins J, Schildberg FW: Host Defence Dysfunction in Trauma, Shock and Sepsis. Berlin, Germany: Springer Verlag, 1993.
2. Chaudry IH, Ayala A: Immunologic Aspects of Trauma Hemorrhage. Austin, Texas: Medical Intelligence Unit, RG. Landes, 1992.
3. Cimbra R, Junger WG, Hoyt DB: Hypertonic saline resuscitation restores hemorrhage-induced immunosuppression by decreasing prostaglandin E2 and IL-4 production. J Surg Res 64:203-209, 1996.
4. Pape HC, Remmers D, Grotz M, Kotzerke J, Dahlweid M, Tscherne H: Reticuloendothelial system activity and organ failure in multiply injured patients. Arch Sur 134:421-424, 1999.
5. Pape HC, Dwenger A, Regel G, Goolub F, Wisner D, Sturm JA, Tscherne H. Increased gut permeability after multiple trauma. Br J Surg 81:850-854, 1994.
6. Schedlowski M, Hosch W, Oberbeck JR, Benshop RJ, Jacobs R, Raab HR, Schmidt RE: Catecholamines modulate human NK-cell circulation and function via spleen-independent β2-adrenergic mechanisms. J Immunol 156:93, 1996.
7. Jetschmann JU, Benshop RJ, Jacobs R, Kemper A, Oberbeck JR, Schmidt RE, Schedlowski M: Expression and in vivo modulation of α- and β-adrenoceptors on human natural killer (CD16) cells. J Neuroimmunol 74:159, 1997.
8. Oberbeck JR, Pape HC, v. Griensven M, Schedlowski M, Nast-Kolb D: β-adrenergic modulation of NK cell migration. Shock 12(Suppl.):39, 1999.
9. Oberbeck R, Dahlweid M, Koch R, Emmendörfer A, Pape HC: Dehydroepiandrosterone decreases mortality rate and improves cellular immune function during polymicrobial sepsis. Crit Care Med 29(2):380-384, 2001.
10. Palm D, Hellenbrecht D, Quiring K: Pharmacology of the noradrenergic and adrenergic system. In Forth W, Hentschel D, Rummel W (ed): Allgemeine und spezielle Pharmakologie, 5th ed. Mannheim, Wien, Zürich: Wissenschaftsverlag, 1987, pp 124-168.
11. Trudeau F, Milot M: Plasma catecholamine response in trained rats following hemorrhage. Can J Appl Physiol 21:481-491, 1996.
12. Johnston IDA, Welbourn RB: Metabolic and endocrine response to trauma. Surg Ann 8:91-101, 1976.
13. Douglas RG, Shaw JHF: Metabolic response to sepsis and trauma. Br J Surg 76:115-122, 1989.
14. Madden KS, Livnat S: Catecholamine action and immunologic reactivity. In Ader R, Felter DL, Cohen N (eds): Psychoneuroimmunology, 2nd ed. San Diego: Academic Press, 1991, pp 283-309.
15. Landmann R: β-adrenergic receptors in human leukocyte subpopulations. Eur J Clin Invest 22:30-36, 1992.
16. Madden KS, Felten DL: Experimental basis for neural-immune interaction. Physiol Rev 75:77-87, 1995.
17. Zapata-Sirvent RL, Hansborough JF, Cox MC, Carter WH: Immunologic alterations in a murine model of hemorrhagic shock. Crit Care Med 20:508-517, 1992.
18. Ertel W, Meldrum DR, Morrison MH: Immunoprotective effect of calcium channel blocker on macrophage antigen presentation function, MHC II function, and interleukin-1 synthesis after hemorrhage. Surgery 108:154-160, 1990.
19. Springer TA: Traffic signal for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301-309, 1994.
20. Janeway CA: Natural killer cells: a primitive immune system. Nature 341:108-110, 1989.
21. Trinchieri G: Biology of natural killer cells. Adv Immunol 47:187-376, 1989.
22. van Tits LJH, Michel C, Grosse-Wilde H, Eigler FW, Soliman A, Brodde OE: Catecholamines increase lymphocyte β2-adrenergic receptors via β2-adrenergic, spleen-independent process. Am J Physiol 258:E191-E202, 1990.
23. Dinarello CA, Mier JW: Lymphokines. N Engl J Med 317:940-945, 1987.
24. Catania RA, Angele MK, Ayala A, Cioffi WG, Bland KI, Chaudry IH: Dehydroepiandrosterone restores immune function following trauma-hemorrhage by a direct effect on T-lymphocytes. Cytokine 6:443-450, 1990.
25. Zellweger R, Zhu X, Wichmann MK, Ayala A, DeMaso C, Chaudry IH: Prolactin administration following hemorrhagic shock improves macrophage cytokine release capacity and decrease mortality from subsequent sepsis. J Immunol 157:5748-5754, 1996.
26. Cohen JJ: Apoptosis. Immunol Today 14:126-130, 1993.
27. Xu XY, Ayala A, Monfils B, Cioffi WG, Chaudry IH: Mechanism of intestinal mucosal immune dysfunction following trauma-hemorrhage: increased apoptosis associated with elevated fas expression in peyers patches. J Surg Res 70: 55-60, 1997.
28. Xu YX, Wichmann MW, Ayala A, Cioffi WG, Chaudry IH: Trauma-hemorrhage induces increased thymic apoptosis while decreasing IL-3 release and increasing GM-CSF. J Surg Res 68:24-30, 1997.
29. Singh K, Communal C, Sawyer DB, Colucci WS: Adrenergic regulation of myocardial apoptosis. Cardiovasc Res 45:713-719, 2000.
30. Josefsson E, Berquist J, Ekamn R, Tarkowski A: Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology 88:140-146, 1996.